» Articles » PMID: 23584108

Anxiety and Alcohol Use Disorders: Comorbidity and Treatment Considerations

Overview
Journal Alcohol Res
Specialty Psychiatry
Date 2013 Apr 16
PMID 23584108
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

The co-occurrence of anxiety disorders and alcohol use disorders (AUDs) is relatively common and is associated with a complex clinical presentation. Sound diagnosis and treatment planning requires that clinicians have an integrated understanding of the developmental pathways and course of this comorbidity. Moreover, standard interventions for anxiety disorders or AUDs may need to be modified and combined in targeted ways to accommodate the unique needs of people who have both disorders. Optimal combination of evidence-based treatments should be based on a comparative balance that considers the advantages and disadvantages of sequential, parallel, and integrated approaches.

Citing Articles

Women Empowered to Connect With Addiction Resources and Engage in Evidence-Based Treatment (WE-CARE)-an mHealth Application for the Universal Screening of Alcohol, Substance Use, Depression, and Anxiety: Usability and Feasibility Study.

Isaacs K, Shifflett A, Patel K, Karpisek L, Cui Y, Lawental M JMIR Form Res. 2025; 9:e62915.

PMID: 39918861 PMC: 11845888. DOI: 10.2196/62915.


Evaluating the synergy: anxiety prevalence and alcohol consumption patterns in high-income countries using Granger causality analysis.

Senarathne B, Palliyaguru D, Oshini A, Gamage J, Jayathilaka R, Rajamanthri L BMC Public Health. 2025; 25(1):220.

PMID: 39828695 PMC: 11744946. DOI: 10.1186/s12889-025-21402-6.


The web-based self-reported survey of Alcohol Use Disorders Identification Test and associated factors in Japan.

Toyama T, Nitta C, Koga Y, Hamanaka K, Kimura M, Matsushita S PCN Rep. 2024; 3(4):e70044.

PMID: 39711579 PMC: 11663248. DOI: 10.1002/pcn5.70044.


A comparative study on hair cortisol concentration among generalized anxiety disorder patients with and without alcohol dependence syndrome presenting to a tertiary care center: A pilot study.

Bijjal S, Huchegowda R, Gowda S, Harbishettar V, Deshpande S, Sharma M Indian J Psychiatry. 2024; 66(9):838-845.

PMID: 39502600 PMC: 11534134. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_520_24.


Chronic ethanol exposure in mice evokes pre- and postsynaptic deficits in GABAergic transmission in ventral tegmental area GABA neurons.

Mitten E, Souders A, Marron Fernandez de Velasco E, Aguado C, Lujan R, Wickman K Br J Pharmacol. 2024; 182(1):69-86.

PMID: 39358985 PMC: 11831720. DOI: 10.1111/bph.17335.


References
1.
Quitkin F, RIFKIN A, Kaplan J, Klein D . Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse. Arch Gen Psychiatry. 1972; 27(2):159-62. DOI: 10.1001/archpsyc.1972.01750260013002. View

2.
Marshall J . Alcohol and substance abuse in panic disorder. J Clin Psychiatry. 1997; 58 Suppl 2:46-9; discussion 49-50. View

3.
Hesse M . Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry. 2009; 9:6. PMC: 2657780. DOI: 10.1186/1471-244X-9-6. View

4.
. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997; 58(1):7-29. View

5.
Petrakis I, Poling J, Levinson C, Nich C, Carroll K, Rounsaville B . Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry. 2005; 57(10):1128-37. DOI: 10.1016/j.biopsych.2005.02.016. View